News & Updates

Aspirin may improve survival in PIK3CA-mutated colon cancer
Aspirin may improve survival in PIK3CA-mutated colon cancer
06 Oct 2024
Serum S-adenosylhomocysteine linked to HCC survival
Serum S-adenosylhomocysteine linked to HCC survival
26 Sep 2024

In patients with hepatocellular carcinoma (HCC), higher serum S-adenosylhomocysteine (SAH) concentrations may contribute to a shorter survival, regardless of the genetic variants of one-carbon metabolism key enzyme, according to a study.

Serum S-adenosylhomocysteine linked to HCC survival
26 Sep 2024